Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Scholar Rock
SRRK
$3.04B
| $843K | ﹤0.01% |
46,300
+9,400
| +25% | +$171K |
|
|
TSC
2202
DELISTED
TriState Capital Holdings, Inc.
TSC
| $841K | ﹤0.01% |
53,538
+8,100
| +18% | +$127K |
|
2203
Passage Bio
PASG
$22.3M
| $839K | ﹤0.01% |
+1,535
| New | +$839K |
|
|
RST
2204
DELISTED
ROSETTA STONE INC
RST
| $833K | ﹤0.01% |
49,400
+8,000
| +19% | +$135K |
|
2205
Resources Connection
RGP
$172M
| $832K | ﹤0.01% |
69,500
+10,500
| +18% | +$126K |
|
2206
Revolution Medicines
RVMD
$8.7B
| $830K | ﹤0.01% |
+26,300
| New | +$830K |
|
2207
Comtech Telecommunications
CMTL
$69.1M
| $828K | ﹤0.01% |
49,000
+1,700
| +4% | +$28.7K |
|
2208
Waterstone Financial
WSBF
$275M
| $828K | ﹤0.01% |
55,800
+8,200
| +17% | +$122K |
|
2209
Agilysys
AGYS
$2.97B
| $823K | ﹤0.01% |
45,900
+6,900
| +18% | +$124K |
|
2210
Aprea Therapeutics
APRE
$8.97M
| $822K | ﹤0.01% |
+1,060
| New | +$822K |
|
2211
Q32 Bio
QTTB
$23.5M
| $822K | ﹤0.01% |
3,006
+900
| +43% | +$246K |
|
|
ALTA
2212
DELISTED
Altabancorp Common Stock
ALTA
| $822K | ﹤0.01% |
36,600
+5,500
| +18% | +$124K |
|
|
FSB
2213
DELISTED
Franklin Financial Network, Inc.
FSB
| $821K | ﹤0.01% |
31,900
+4,800
| +18% | +$124K |
|
2214
Forrester Research
FORR
$195M
| $819K | ﹤0.01% |
25,550
+3,900
| +18% | +$125K |
|
2215
Customers Bancorp
CUBI
$2.32B
| $816K | ﹤0.01% |
67,900
+10,200
| +18% | +$123K |
|
2216
Clear Channel Outdoor Holdings
CCO
$651M
| $812K | ﹤0.01% |
780,300
+57,200
| +8% | +$59.5K |
|
2217
World Acceptance Corp
WRLD
$900M
| $812K | ﹤0.01% |
12,400
+900
| +8% | +$58.9K |
|
|
UBA
2218
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $811K | ﹤0.01% |
68,236
+10,300
| +18% | +$122K |
|
|
HIBB
2219
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $810K | ﹤0.01% |
38,700
+4,400
| +13% | +$92.1K |
|
|
GOGL
2220
DELISTED
Golden Ocean Group
GOGL
| $808K | ﹤0.01% |
210,922
+45,217
| +27% | +$173K |
|
|
BDSI
2221
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $805K | ﹤0.01% |
184,700
+27,800
| +18% | +$121K |
|
2222
McEwen Inc.
MUX
$748M
| $803K | ﹤0.01% |
79,533
+18,080
| +29% | +$183K |
|
|
BSTC
2223
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $803K | ﹤0.01% |
13,100
+2,600
| +25% | +$159K |
|
2224
Liberty Energy
LBRT
$1.73B
| $802K | ﹤0.01% |
146,300
+35,900
| +33% | +$197K |
|
2225
Beam Therapeutics
BEAM
$2.08B
| $801K | ﹤0.01% |
+28,600
| New | +$801K |
|